<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02288780</url>
  </required_header>
  <id_info>
    <org_study_id>4-2014-0734</org_study_id>
    <nct_id>NCT02288780</nct_id>
  </id_info>
  <brief_title>Transthoracic Echocardiographic Evaluation of the Cardiac Function During Transurethral Resection of Prostate in Elderly Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transurethral resection of the prostate (TURP) is a standard surgical treatment for benign
      prostatic hyperplasia (BPH). Non-conductive irrigation fluid is used to maintain good
      visibility of the operating field during resection of the prostate. Absorption of this
      hypotonic solution into the bloodstream can cause fluid overload and dilutional hyponatremia,
      resulting in adverse cardiovascular and central nervous system effects, transurethral
      resection (TUR) syndrome. BPH is common in elderly men above 60 years old. These aged people
      commonly have diastolic impairment by normal physiologic change without consistent symptom.
      This study aimed to evaluate the cardiac function focused mainly diastolic function during
      TURP with transthoracic echocardiography. Also, we will focus the effets of amount of
      irrgation fluid on left ventricular diastolic function in patients with pre-existing
      diastolic dysfunction.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    It was difficult to proceed with the study according to the protocol, the research was
    terminated early.
  </why_stopped>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Actual">May 1, 2015</completion_date>
  <primary_completion_date type="Actual">May 1, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>diastolic function by TTE</measure>
    <time_frame>The participants will be followed for the duration of surgery (TURP), an expected average of 1 hour.</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2</enrollment>
  <condition>BPH</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>BPH patients with normal diastolic function</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diastolic dysfunction</arm_group_label>
    <description>BPH patients with preoperative diastolic dysfunction</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        BPH patients with/without preoperative diastolic dysfunction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Above 65years of age

          2. American Society of Anesthesiologists (ASA) Physical Status I, II, III.

          3. undergoing transurethral resection of the prostate(TURP)&quot;

        Exclusion Criteria:

          1. severe coagulopathy or bleeding disorder(platelet count&lt;75000, PT INR &gt;1.2)

          2. short stature (under 150 cm)

          3. underwent coronary artery bypass graft

          4. contraindications of regional anesthesia &quot;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>November 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2014</study_first_posted>
  <last_update_submitted>March 14, 2019</last_update_submitted>
  <last_update_submitted_qc>March 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

